US 12054553
Immunotherapeutic tumor treatment method
granted A61KA61K2039/505A61K31/4745
Quick answer
US patent 12054553 (Immunotherapeutic tumor treatment method) held by Nektar Therapeutics expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/505, A61K31/4745, A61K38/20, A61K39/39541